Company Filing History:
Years Active: 1989-1993
Title: Tohru Ishizuka: Innovator in Pharmaceutical Chemistry
Introduction
Tohru Ishizuka is a notable inventor based in Kitamoto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 3 patents to his name, Ishizuka's work has the potential to impact medical treatments significantly.
Latest Patents
Ishizuka's latest patents include innovative compounds that demonstrate promising pharmacological properties. One of his notable inventions is a benzocycloheptene derivative, which exhibits excellent inhibitory activity against the contraction of the urinary bladder. This compound is characterized by a specific formula where R¹ can be a hydrogen atom, a halogen atom, or a lower alkoxy group, while R² and R³ can vary, providing versatility in its application.
Another significant patent is for a benzofuran derivative, which also shows potent inhibitory activity against reflective contractions of the urinary bladder. This compound features a unique structure where R¹ can be a hydrogen atom, a lower alkoxy group, or a halogen atom, and it includes various configurations for R² and R³, enhancing its therapeutic potential.
Career Highlights
Throughout his career, Tohru Ishizuka has worked with reputable companies, including Tanabe Seiyaku Company, Limited and Tanabe Seikayu Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Ishizuka has collaborated with esteemed colleagues such as Masakatsu Ozeki and Kunio Nosaka. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Tohru Ishizuka stands out as an influential inventor in the realm of pharmaceutical chemistry. His innovative patents and collaborations reflect his commitment to advancing medical science and improving therapeutic options for patients.